Engineering a Dynamic Controllable Infectivity Switch in Bacteriophage T7

ACS Synth Biol. 2022 Jan 21;11(1):286-296. doi: 10.1021/acssynbio.1c00414. Epub 2022 Jan 5.

Abstract

Transcriptional repressors play an important role in regulating phage life cycle. Here, we examine how synthetic transcription repressors can be used in bacteriophage T7 to create a dynamic, controllable infectivity switch. We engineered T7 phage by replacing a large region of the early phage genome with different combinations of ligand-responsive promoters and ribosome binding sites (RBS) designed to control the phage RNA polymerase, gp1. Phages with engineered infectivity switch are fully viable at levels comparable to wildtype T7, when not repressed, indicating the phage can be engineered without loss of fitness. The most effective switch used a TetR-responsive promoter and an attenuated RBS, resulting in a 2-fold increase in latent period and a 10-fold decrease in phage titer when repressed. Phage activity can be further tuned using different inducer concentrations. Our study provides a proof of concept for how a simple synthetic circuit introduced into the phage genome enables user control over phage infectivity.

Keywords: engineered bacteriophages; enterobacteria phage T7; ligand-responsive repression system; pseudolysogenic.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacteriophage T7* / genetics
  • Bacteriophages* / genetics
  • DNA-Directed RNA Polymerases / genetics
  • Promoter Regions, Genetic / genetics
  • Transcription Factors / genetics

Substances

  • Transcription Factors
  • DNA-Directed RNA Polymerases